Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin
This article was originally published in The Pink Sheet
In advance of a US FDA advisory panel meeting on the safety of OTC monograph antacid/aspirin products, Bayer is removing aspirin from its pioneering Alka-Seltzer effervescent indigestion products. Bayer's Andre Schmidt talks about the safety advantages and consumer trends that helped spur the change.
You may also be interested in...
The US Nonprescription Drugs and Drug Safety and Risk Management advisory committees will discuss the safety of using OTC analgesic combination products for upset stomach and hangover even though Drug Facts labels already warn about the risk of serious bleeding.
FDA's final rule for OTC products containing acetaminophen or nonsteroidal anti-inflammatory drugs requires warnings and revisions that go beyond changes the agency proposed in a 2006 tentative final rule
Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.